Home > Center for Toxicology & Human Health

UL Research Institutes’ Chemical Insights’ Center for Toxicology & Human Health studies the health impacts of chemical exposures from consumer products, occupational settings, indoor environments, and environmental events. Researchers use advanced toxicological approaches to investigate biological responses, characterize exposure-related health risks, and evaluate mechanisms that may contribute to disease.

Toxicology helps determine what chemicals do once exposure occurs. While exposure science examines how people come into contact with chemicals, toxicology evaluates how those chemicals interact with biological systems and whether they may cause adverse health effects. The Center addresses these questions through research focused on human-relevant biological responses, toxicological mechanisms, and health risk assessment. 

This work supports researchers, public health professionals, policymakers, regulatory agencies, industry stakeholders, and communities seeking evidence-based information about human health research related to toxic chemical exposure.

Research Focus

The Center studies how chemical exposures affect biological systems and contribute to potential health outcomes. This work helps identify the biological mechanisms that underlie exposure-related health effects and supports evidence-based approaches to chemical safety and public health protection.

 

Vaping exposure

Vaping and electronic nicotine delivery systems (ENDS) can expose users and bystanders to hazardous chemicals, heavy metals, and particulate matter. The Center studies the toxicological effects of vaping-related exposures and evaluates how emissions may affect the respiratory system, cardiovascular health, and oral health. Research examines chemical profiles of emissions, biological responses at the cellular and tissue level, and mechanisms that contribute to potential health effects. This work supports public health understanding of vaping-related exposures and improves understanding of indoor air quality health effects associated with vaping emissions.

 

Disease mechanisms and biomarkers

Disease mechanism research examines how chemical exposures contribute to biological changes that may precede or promote adverse health outcomes. The Center studies cellular and molecular pathways involved in toxic responses, including processes related to inflammation, oxidative stress, cellular signaling, and tissue-level effects where supported by the model system. Biomarker research helps connect these biological changes to measurable indicators of exposure or response. Together, these studies strengthen interpretation of exposure-related health effects and support more evidence-based risk assessment. 

 

PFAS and human health

Per- and polyfluoroalkyl substances (PFAS) are a priority area for toxicology and human health research because of their persistence, widespread occurrence, and potential biological effects. The Center studies how PFAS exposures may affect human-relevant biological systems and contribute to toxicity pathways. Research evaluates cellular responses, exposure-related mechanisms, and health-relevant endpoints associated with PFAS. These studies support chemical hazard assessment and help strengthen understanding of PFAS-related health risks. 

Scientific Capabilities

Human-relevant toxicology models

Human-relevant toxicology models provide information that better reflects biological responses relevant to human health than simplified test systems alone. The Center uses organotypic and in vitro culture models to study chemical effects in systems that preserve aspects of tissue structure, function, or multicellular interaction, such as precision-cut lung slices.

 

Multi-omic profiling and biomarker analysis

Multi-omic profiling can evaluate biological responses across multiple molecular layers, including transcriptomic, proteomic, and metabolomic. These approaches help identify pathways affected by chemical exposure and provide insight into mechanisms that may not be visible through a single endpoint. Biomarker analysis can help connect molecular-level changes with indicators of exposure or potential adverse effect.

 

Toxicological screening and mechanistic workflows

Toxicological screening supports evaluation of chemical activity across defined biological endpoints or exposure conditions. Mechanistic workflows integrate exposure characterization, laboratory models, biological assays, and molecular analysis to investigate how chemicals produce toxic effects. Together, these approaches support hazard identification, prioritization, and interpretation of exposure-related disease pathways.

 

Specialized equipment & instrumentation

  • Air-liquid interface exposure system
  • ENDS aerosol generation system (EAGS)
  • Flow cytometer
  • Multiplex assay instrument system
  • Franz diffusion instrument
  • Real-time/Reverse transcriptase (RT) PCR system
  • Live-cell metabolic analyzer
  • Genomic sequencing machine
  • Zetasizer
  • Tape station
  • Hyperspectral microscopy
  • Western blot system
  • Thermocycler
  • Spectral photometer and confocal microscope
  • Live cell imaging

Collaboration Opportunities

The Center for Toxicology & Human Health is interested in collaborating with:

  • Academic toxicologists and environmental health researchers
  • Public health agencies and healthcare researchers evaluating exposure-related disease
  • Government organizations investigating chemical safety and hazard characterization
  • Industry partners working on consumer product safety, vaping devices, or emerging exposure sources
  • Environmental health and community-focused organizations addressing exposure-related risks

Center Leadership

 

Mark Wilson, Ph.D., director of the Center for Analytics & Exposure Science, poses for his professional headshot.

Mark Wilson, Ph.D., MSPH, CIH

Interim Director of the Center for Toxicology & Human Health

(Director of the Center for Analytical & Exposure Science)

 

Mark Wilson, Ph.D., MSPH, CIH, is the interim director for the Center of Toxicology & Human Health and the research director for the Center for Analytical & Exposure Science within UL Research Institutes’ Chemical Insights in Marietta, Georgia. His work aims to characterize exposures associated with various occupational and environmental scenarios to evaluate health risks. Mark’s methodology is based on the collection of various environmental samples (air, water, food, dust/soil) to determine the presence and quantify the levels of chemical hazards present. These data are integrated into exposure models to estimate exposure levels to chemicals of concern that are evaluated for acceptability by comparison to regulatory or health-based criteria.

Mark received a Ph.D. and a Masters in Toxicology from Tulane University, School of Public Health and Tropical Medicine, in New Orleans, Louisiana. After graduate school, he completed a postdoctoral fellowship at Tulane University. During this time, Mark was involved in dietary health risk assessments focused on the impact of the Deepwater Horizon (BP) oil spill on seafood safety in the Gulf of Mexico and developed in vitro methodology to evaluate the toxic potential for chemical agents with little to no regulatory and toxicological information.

ORCiD: 0000-0003-0427-9689

Selected Research

decorative abstract background

Get in Touch

Address: 2211 Newmarket Parkway, STE 106, Marietta, GA 30067, U.S.A.

Email: ChemicalInsights@ul.org

Phone number: 470-924-9040

Connect with our team to explore research partnerships and collaborative opportunities.